Abstract: The present disclosure pertains to an image forming apparatus that may include a hardware processor that may: receive a print job; acquire position information of a user; determine an output mode of a printed matter on the basis of the acquired position information; and execute the print job and output the printed matter in the determined output mode.

Abstract: The present disclosure pertains to an image forming apparatus that may include a hardware processor that may: receive a print job; acquire position information of a user; determine an output mode of a printed matter on the basis of the acquired position information; and execute the print job and output the printed matter in the determined output mode.

Abstract: A processor capable of executing predetermined processing includes: a communication interface for communicating with a host device which requests the execution of the processing; a main control unit configured to control the execution of the processing; a notification unit which does not proceed to a power saving mode but executes notification processing for allowing the host device to detect that an operating mode of the main control unit is in the power saving mode when the main control unit proceeds to the power saving mode reducing power consumption; and a state switching unit configured to allow the communication interface to proceed to a power saving state of which power consumption is smaller than that of a normal state when the communication interface receives a power saving command from the host device.

Abstract: A processor capable of executing predetermined processing includes: a communication interface for communicating with a host device which requests the execution of the processing; a main control unit configured to control the execution of the processing; a notification unit which does not proceed to a power saving mode but executes notification processing for allowing the host device to detect that an operating mode of the main control unit is in the power saving mode when the main control unit proceeds to the power saving mode reducing power consumption; and a state switching unit configured to allow the communication interface to proceed to a power saving state of which power consumption is smaller than that of a normal state when the communication interface receives a power saving command from the host device.

Abstract: Disclosed is an image processing apparatus including: a control unit; an image forming unit; a storing unit; and a job reception unit, wherein in case that the control unit identifies that the print job received while the job reception unit receives the print job group is another print job received from another external device in accordance with the identification information, the control unit controls the storing unit so as to hold the another print job until the image forming unit completes the image forming in accordance with the print job group, and after the image forming unit completes the image forming in accordance with the print job group, the control unit controls the image forming unit so as to start the image forming in accordance with the another print job.

Abstract: An image formation apparatus having a plurality of function units includes: a first power management unit configured to perform power management; a plurality of components under the power management, provided in each function unit and each supplied with power to implement a corresponding function; and a second power management unit provided for each function unit. The second power management unit is configured to determine whether each component has an operational status satisfying a first predetermined condition, to stop supplying power to the component satisfying the first predetermined condition, if the component satisfies the first predetermined condition, to determine whether the plurality of components have a power supply status satisfying a second predetermined condition, and to change the first predetermined condition in content, if the second predetermined condition is satisfied.

Abstract: Disclosed is an image processing apparatus including: a control unit; an image forming unit; a storing unit; and a job reception unit, wherein in case that the control unit identifies that the print job received while the job reception unit receives the print job group is another print job received from another external device in accordance with the identification information, the control unit controls the storing unit so as to hold the another print job until the image forming unit completes the image forming in accordance with the print job group, and after the image forming unit completes the image forming in accordance with the print job group, the control unit controls the image forming unit so as to start the image forming in accordance with the another print job.

Abstract: An image formation apparatus having a plurality of function units includes: a first power management unit configured to perform power management; a plurality of components under the power management, provided in each function unit and each supplied with power to implement a corresponding function; and a second power management unit provided for each function unit. The second power management unit is configured to determine whether each component has an operational status satisfying a first predetermined condition, to stop supplying power to the component satisfying the first predetermined condition, if the component satisfies the first predetermined condition, to determine whether the plurality of components have a power supply status satisfying a second predetermined condition, and to change the first predetermined condition in content, if the second predetermined condition is satisfied.

Abstract: A resin composition comprising a 2-(1-arylalkylidene) acetic ester and at least one resin selected from a methyl methacrylate resin, a styrene resin and a methyl methacrylate-styrene copolymer resin is provided, wherein the acetic ester is contained in the composition in an amount of from about 0.0005 part by weight to about 0.1 part by weight with respect to 100 parts by weight of the resin. The resin composition is improved in durability without deteriorating the excellent properties of the resin, such as being colorless and transparent.

Abstract: There is provided an industrial production method of an aminopyrrolidine derivative having chemokine receptor antagonist activity represented by the following formula, a synthetic intermediate thereof and a production method thereof: wherein R11 is H, C1-C6 alkyl or C2-C7 alkanoyl; R12, R14, R15, R16 and R17 are H, halogen, optionally halogenated C1-C6 alkyl, optionally halogenated C1-C6 alkoxy, hydroxyl or C2-C7 alkoxycarbonyl; R23, R24, R25 and R26 are H, halogen, optionally halogenated C1-C6 alkyl, optionally halogenated C1-C6 alkoxy or hydroxyl; and R3 is H or C1-C6 alkyl.

Abstract: Compounds expressed by the following general formula (1), [wherein, R01 and R02 are each independently a hydrogen atom or a protecting group for a hydroxyl group; Z is one out of the following formulae (1-1), (1-2), (1-3), (1-4) and (1-5)]. The compounds can be used as active ingredients of treating agents for inflammatory respiratory diseases, malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage.

Abstract: A vitamin D3 derivative expressed by the following general formula (1) [wherein, R is a hydrogen atom or a methyl group, and A is a single bond, —CH2—, —CH?CH—, —CH2—CH?CH—, —CH?CH—CH?CH—, —C?C— or —CH2—C?C—; and a compound in which R is an hydrogen atom, A is —CH2—, the steric configuration at the 1-position is (S)-configuration, and the steric configuration at the 3-position is (R)-configuration is excluded] or a pharmaceutically permissible solvate thereof. The compound can be an effective ingredient of a treating agent for osteoporosis, malignant tumor, psoriasis, hyperparathyroidism, an inflammatory respiratory disease, rheumatoid arthritis, growth onset type diabetes mellitus, hypertension, alopecia, acne, dermatitis, hypercalcemia or Paget's disease of bone.

Abstract: An agent for suppressing the production of parathyroid hormone and a remedy for hyperparathyroidism containing a vitamin D3 derivative described by the following general formula (1) [in the formula, m is an integer of from 1 to 3, q is an integer of from 0 to 3, r is an integer of from 0 to 3 and X is carbon atom or oxygen atom, provided that 1?q+r?3] as an active ingredient.

Abstract: Compounds expressed by the following general formula (1), [wherein, R01 and R02 are each independently a hydrogen atom or a protecting group for a hydroxyl group; Z is one out of the following formulae (1-1) to (1-5)]. The compounds can be used as active ingredients of treating agents for inflammatory respiratory diseases, malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage.

Abstract: A resin composition comprising a 2-(1-arylalkylidene) acetic ester and at least one resin selected from a methyl methacrylate resin, a styrene resin and a methyl methacrylate-styrene copolymer resin is provided, wherein the acetic ester is contained in the composition in an amount of from about 0.0005 part by weight to about 0.1 part by weight with respect to 100 parts by weight of the resin. The resin composition is improved in durability without deteriorating the excellent properties of the resin, such as being colorless and transparent.

Abstract: A resin plate comprising a base layer and a surface layer placed on at least one side of the base layer is provided. The base layer is made from a methyl methacrylate polymer having about 30% by weight or more of a methyl methacrylate unit as a monomer unit, and the surface layer has a thickness of about 5 &mgr;m to about 500 &mgr;m and is made from a resin composition containing about 40 parts by weight to about 95 parts by weight of a methyl methacrylate resin and about 5 parts by weight to about 60 parts by weight of a vinylidene fluoride resin with respect to 100 parts by weight in total of the methyl methacrylate resin and the vinylidene fluoride resin. The resin plate has a superior transparency and little deformation due to moisture absorption.

Abstract: A process for producing an article of resin made from at least about 50% by weight of methyl methacrylate is provided, which comprises a step of melt-processing the resin with an extruder, wherein an oxygen concentration of a gaseous phase in a resin feed zone of the extruder falls within a range of from about 0.7% by volume to about 10% by volume. The article is excellent in curbing the coloring in melt processing.

Abstract: Compounds expressed by the following general formula (1), [wherein, R01 and R02 are each independently a hydrogen atom or a protecting group for a hydroxyl group; Z is one out of the following formula (1-5)]. The compounds can be used as active ingredients of treating agents for inflammatory respiratory diseases, malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage.

Abstract: The invention provides a resin molded article for optical products comprising a copolymer predominantly composed of methyl methacrylate and a styrenic monomer, wherein the number of foreign bodies contained in the resin molded article having a length of 210 mm, a width of 210 mm and a thickness of 3 mm as visually examined using a strain meter is about 150 or less, which is useful for a light transmitting plate employed in a liquid crystal display device because the possibility that the display screen looks whitely turbid due to the warp of the light transmitting plate, is reduced.

Abstract: Compounds expressed by the following general formula (1), [wherein, R01 and R02 are each independently a hydrogen atom or a protecting group for a hydroxyl group; Z is one out of the following formulae (1-1) to (1-5)]. The compounds can be used as active ingredients of treating agents for inflammatory respiratory diseases, malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage.